Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

115 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Infectiousness of HIV between male homosexual partners.
DeGruttola V, Seage GR 3rd, Mayer KH, Horsburgh CR Jr. DeGruttola V, et al. J Clin Epidemiol. 1989;42(9):849-56. doi: 10.1016/0895-4356(89)90098-x. J Clin Epidemiol. 1989. PMID: 2789269
The value of AIDS incidence data in assessing the spread of HIV infection.
De Gruttola V, Lagakos SW. De Gruttola V, et al. Stat Med. 1989 Jan;8(1):35-43. doi: 10.1002/sim.4780080106. Stat Med. 1989. PMID: 2919246
Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology Laboratories.
DeGruttola V, Beckett LA, Coombs RW, Arduino JM, Balfour HH Jr, Rasheed S, Hollinger FB, Fischl MA, Volberding P. DeGruttola V, et al. J Infect Dis. 1994 Apr;169(4):713-21. doi: 10.1093/infdis/169.4.713. J Infect Dis. 1994. PMID: 8133085 Clinical Trial.
Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group.
D'Aquila RT, Johnson VA, Welles SL, Japour AJ, Kuritzkes DR, DeGruttola V, Reichelderfer PS, Coombs RW, Crumpacker CS, Kahn JO, Richman DD. D'Aquila RT, et al. Ann Intern Med. 1995 Mar 15;122(6):401-8. doi: 10.7326/0003-4819-122-6-199503150-00001. Ann Intern Med. 1995. PMID: 7856987 Clinical Trial.
Virologic and regimen termination surrogate end points in AIDS clinical trials.
Gilbert PB, DeGruttola V, Hammer SM, Kuritzkes DR. Gilbert PB, et al. JAMA. 2001 Feb 14;285(6):777-84. doi: 10.1001/jama.285.6.777. JAMA. 2001. PMID: 11176916
Perspective: human immunodeficiency virus type 1 (HIV-1) RNA end points in HIV clinical trials: issues in interim monitoring and early stopping.
Zackin R, Marschner I, Andersen J, Cowles MK, De Gruttola V, Hammer S, Fischl M, Cotton D. Zackin R, et al. J Infect Dis. 1998 Mar;177(3):761-5. doi: 10.1086/514244. J Infect Dis. 1998. PMID: 9498459 Review.
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy.
Marschner IC, Collier AC, Coombs RW, D'Aquila RT, DeGruttola V, Fischl MA, Hammer SM, Hughes MD, Johnson VA, Katzenstein DA, Richman DD, Smeaton LM, Spector SA, Saag MS. Marschner IC, et al. J Infect Dis. 1998 Jan;177(1):40-7. doi: 10.1086/513823. J Infect Dis. 1998. PMID: 9419168 Clinical Trial.
115 results
Jump to page
Feedback